EUCTR2018-000578-31-DE进行中（未招募）1 期
Impact of benralizumab treatment on circulating dendritic cells in patients with eosinophilic asthma
niversity Medicine Rostock0 个研究点目标入组 20 人开始时间: 2018年4月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Blood eosinophils > 300 cells / µl blood
- •ICS-LABA-Therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Current Smoking
- •Immunosuppression (except ICS)
- •Other chronic inflammatory diseases
研究者
相似试验
进行中（未招募）
4 期
Tokyo Asthma Study; TOASTSevere asthmaJPRN-jRCTs031190237Fukunaga Koichi100
Unknown
4 期
Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic AsthmaSevere Eosinophilic AsthmaNCT03652376University of Rostock20
尚未招募
不适用
An exploratory study to assess the effect of benralizumab on small airway obstruction in patients with severe asthma using functional respiratory imagingasthmaNL-OMON26915Ciro20
进行中（未招募）
1 期
BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma using Functional Respiratory ImagingMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2022-000152-11-PTAstraZeneca AB38
进行中（未招募）
1 期
BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma using Functional Respiratory ImagingAsthmaEUCTR2022-000152-11-FRAstraZeneca AB199